Russia plans mass inoculation in Oct using coronavirus vaccine: Report

Health Minister says clinical trials are over for vaccine developed by Moscow-based institute.

covid-19, vaccine, coronavirus
IANS
1 min read Last Updated : Aug 02 2020 | 10:57 AM IST
Russia plans a mass vaccination campaign against the novel coronavirus for October, Health Minister Mikhail Murashko said.

"We plan wider (vaccination) for October because we need to launch a new system of treatment gradually," the Minister told TASS News Agency on Saturday.

Murashko said clinical trials of a coronavirus vaccine developed by Moscow's Gamaleya Scientific Research Institute of Epidemiology and Microbiology were over.

The vaccination will be free of charge, the Minister added.

"We plan that the coronavirus vaccination campaign will be totally covered from the budget. Accordingly, the vaccination scheme is known to all. It will be planned," he said.

Last month, Prime Minister Mikhail Mishustin said that he was hopeful that Russia will produce a reliable vaccine against COVID-19 by the fall.

To date, 845,443 coronavirus cases have been confirmed in Russia, with 646,524 patients having recovered from the disease.

Russia's latest data indicates 14,058 fatalities nationwide.

Earlier, the Russian government set up an Internet hotline to keep the public updated on the coronavirus situation.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccineCoronavirus Tests

Next Story